Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant nonsyndromic deafness in which the cause of the disease is a mutation in the CRYM gene.
Features include always present findings: Inner ear hearing loss (sensorineural hearing impairment). 3 total HPO annotations.
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 3:07 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 2 | Abnormal vestibular function, Inner ear hearing loss (sensorineural hearing impairment) |
Brain and nerves | 1 | Intellectual disability |
CRYM encodes crystallin mu (314 aa). Catalyzes the NAD(P)H-dependent reduction of imine double bonds of a number of cyclic ketimine substrates, including sulfur-containing cyclic ketimines. Highest expression in Brain Nucleus accumbens basal ganglia (153.7 TPM) and Brain Cerebellar Hemisphere (150.5 TPM).
Autosomal dominant nonsyndromic hearing loss 40 is associated with mutations in the CRYM gene on chromosome 16.
The CRYM protein participates in CRYM reduces P2C to PPCA pathway.
CRYM is classified as a druggable target (Enzyme and Nuclear Hormone Receptor categories) with score 0.0.
Genetic testing for CRYM is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal dominant nonsyndromic hearing loss 40 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature.
No clinical trials have been registered for autosomal dominant nonsyndromic hearing loss 40.
11 publications have been identified in PubMed for autosomal dominant nonsyndromic hearing loss 40. Research spans Case Report / Case Series (36%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 36% |
Laboratory research | 3 | 27% |
Disease patterns and progression | 2 | 18% |
Testing and diagnosis research | 1 | 9% |
Research summaries | 1 | 9% |
Peng LT (2026). [PMID: 41351289](https://pubmed.ncbi.nlm.nih.gov/41351289/). *J Clin Lab Anal*. [Basic Science / Preclinical]
Gong GQ (2025). [PMID: 40052770](https://pubmed.ncbi.nlm.nih.gov/40052770/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Wu KL (2025). [PMID: 40413265](https://pubmed.ncbi.nlm.nih.gov/40413265/). *Sci Rep*. [Case Report / Case Series]
Machado T (2025). [PMID: 39806488](https://pubmed.ncbi.nlm.nih.gov/39806488/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Arif AR (2025). [PMID: 39672236](https://pubmed.ncbi.nlm.nih.gov/39672236/). *J Thromb Haemost*. [Epidemiology / Natural History]
Valenciaga A (2025). [PMID: 39822657](https://pubmed.ncbi.nlm.nih.gov/39822657/). *JCEM Case Rep*. [Case Report / Case Series]
Daenen M (2025). [PMID: 39837581](https://pubmed.ncbi.nlm.nih.gov/39837581/). *Nephrol Dial Transplant*. [Basic Science / Preclinical]
Yu S (2024). [PMID: 39720982](https://pubmed.ncbi.nlm.nih.gov/39720982/). *Mol Genet Genomics*. [Basic Science / Preclinical]
Zhang L (2024). [PMID: 39556694](https://pubmed.ncbi.nlm.nih.gov/39556694/). *Adv Sci (Weinh)*. [Review / Meta-Analysis]
Niehues T (2024). [PMID: 39381601](https://pubmed.ncbi.nlm.nih.gov/39381601/). *Allergol Select*. [Diagnostic / Biomarker]